Heregulin can activate HER3-promoted signaling pathways via HER1/HER3 or HER2/HER3 heterodimers [23]; however, it has not been elucidated so far which of these heterodimers mediate these pro-survival effects in MET addicted gastric cancer cells. The gene discussed is EGFR; the disease is gastric cancer.